| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |